Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bardet-Biedl syndrome 5 | 0.659 | 0.577 | 4.8E-06 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
Bardet-Biedl syndrome 7 | 0.682 | 0.462 | 7.1E-09 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
MKS transition zone complex subunit 1 | 0.505 | 0.769 | 3.4E-16 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
ADP ribosylation factor like GTPase 6 | 0.636 | 0.462 | 1.0E-02 |
|
disease | 0.400 | strong | 0 | 1 | |||||||||||
|
Bardet-Biedl syndrome 12 | 0.674 | 0.462 | 2.3E-07 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
tetratricopeptide repeat domain 8 | 0.631 | 0.500 | 1.2E-06 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
citrate synthase | 0.590 | 0.654 | 0.98 |
|
disease | 0.310 | None | 0.500 | 1 | 0 | 2011 | 2017 | ||||||||
|
Rap guanine nucleotide exchange factor 3 | 0.593 | 0.692 | 7.1E-23 |
|
disease | 0.320 | None | 0.667 | 1 | 0 | 2016 | 2018 | ||||||||
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
disease | 0.420 | None | 0.750 | 2 | 0 | 2004 | 2011 | ||||||||
|
phosphoenolpyruvate carboxykinase 1 | 0.608 | 0.538 | 8.7E-15 |
|
disease | 0.330 | None | 0.750 | 1 | 0 | 2007 | 2015 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
disease | 0.520 | None | 0.750 | 1 | 0 | 1996 | 2007 | ||||||||
|
syndecan 3 | 0.711 | 0.654 | 0.41 |
|
disease | 0.440 | None | 0.750 | 0 | 0 | 2006 | 2018 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.498 | 0.808 | 5.0E-08 |
|
disease | 0.700 | moderate | 0.786 | 0 | 0 | 2001 | 2019 | ||||||||
|
potassium channel tetramerization domain containing 15 | 0.792 | 0.192 | 3.6E-02 |
|
disease | 0.390 | None | 0.800 | 1 | 0 | 2009 | 2018 | ||||||||
|
CD163 molecule | 0.427 | 0.846 | 8.3E-04 |
|
disease | 0.350 | None | 0.833 | 1 | 0 | 2009 | 2018 | ||||||||
|
McKusick-Kaufman syndrome | 0.566 | 0.692 | 2.1E-09 |
|
disease | 0.660 | strong | 0.833 | 0 | 0 | 2000 | 2013 | ||||||||
|
glucosamine-6-phosphate deaminase 2 | 0.792 | 0.346 | 8.5E-03 |
|
disease | 0.400 | None | 0.846 | 1 | 0 | 2009 | 2019 | ||||||||
|
TNF receptor superfamily member 1B | 0.425 | 0.885 | 0.50 |
|
disease | 0.360 | None | 0.857 | 1 | 0 | 2000 | 2008 | ||||||||
|
proprotein convertase subtilisin/kexin type 1 | 0.548 | 0.615 | 2.7E-09 |
|
disease | 0.700 | None | 0.857 | 1 | 0 | 1997 | 2018 | ||||||||
|
adrenoceptor beta 1 | 0.555 | 0.769 | 2.9E-06 |
|
disease | 0.370 | None | 0.875 | 1 | 0 | 1997 | 2018 | ||||||||
|
mitochondrial carrier 2 | 0.821 | 0.269 | 3.2E-02 |
|
disease | 0.370 | None | 0.875 | 1 | 0 | 2009 | 2017 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.400 | None | 0.881 | 2 | 0 | 1997 | 2019 | ||||||||
|
uncoupling protein 2 | 0.493 | 0.808 | 1.5E-10 |
|
disease | 0.400 | None | 0.882 | 1 | 0 | 1997 | 2019 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.500 | None | 0.884 | 1 | 0 | 1997 | 2019 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
disease | 0.500 | None | 0.895 | 4 | 0 | 1989 | 2019 |